SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancerFatimah Matalkah(West Virginia University), Yehenew M. Agazie(West Virginia University)Breast Cancer ResearchJanuary 4, 201610.1186/s13058-015-0659-zCited by 52SaveCiteExport RISWatch citationsRelated PapersInhibition of SHP2 in basal-like and triple-negative breast cells induces basal-to-luminal transition, hormone dependency, and sensitivity to anti-hormone treatment|BMC Cancer|2015|20